The DOI matches its Crossref record; 238 of the 239 references it cites were found in a registry or an index.
Linking oxidative stress biomarkers to disease progression and antioxidant therapy in hypertension and diabetes mellitus
Open accessAbstract
Oxidative stress (OS) is increasingly recognized as a key factor linking hypertension (HTN) and diabetes mellitus (DM). This review summarizes recent evidence regarding the dual role of OS as both an instigator and an amplifier of cardiometabolic dysfunction. In HTN, reactive oxygen species (ROS) produced by NADPH oxidases (NOXs) and mitochondrial dysfunction contribute to endothelial impairment and vascular remodeling. In DM, hyperglycemia-induced ROS production worsens beta-cell failure and insulin resistance through pathways such as the AGE-RAGE signaling, protein kinase C (PKC) activation, and the polyol pathway. Clinically validated biomarkers of OS, such as F2-isoprostanes (which indicate lipid peroxidation), 8-OHdG (which indicates DNA damage), and the activities of redox enzymes like superoxide dismutase (SOD) and glutathione peroxidase (GPx), show strong correlations with disease progression and end-organ complications. Despite promising preclinical results, the application of antioxidant therapies in clinical settings has faced challenges due to inconsistent outcomes, highlighting the need for targeted approaches. Emerging strategies include: 1. Mitochondria-targeted antioxidants to enhance vascular function in resistant HTN; 2. Nrf2 activators to restore redox balance in early diabetes; and 3. Specific inhibitors of NOX isoforms. We emphasize three transformative areas of research: (i) the interaction between the microbiome and ROS, where modifying gut microbiota can reduce systemic OS; (ii) the use of nanotechnology to deliver antioxidants directly to pancreatic islets or atherosclerotic plaques; and (iii) phenotype-specific diagnosis and therapy guided by redox biomarkers and genetic profiling (for example, KEAP1/NRF2 polymorphisms). Integrating these advances with lifestyle modifications, such as following a Mediterranean diet and exercising regularly, may provide additional benefits. This review outlines a mechanistic framework for targeting OS in the comorbidity of HTN and DM while identifying critical knowledge gaps, particularly regarding the timing of antioxidant signaling and the development of personalized redox medicine, which may serve as a reference for researchers and clinicians working in this area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This supports the idea that lipid peroxidation markers may serve as mechanistically plausible candidate predictors; however, the present evidence base remains heterogeneous in marker selection, assay platform, and standardization, and direct comparative evidence against standard clinic-based models is still limited (20–22).”
From AI-driven cardiovascular risk prediction in patients with diabetes: bridging algorithmic innovation to equitable clinical application (2026) · cites this paper as [22]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This supports the idea that lipid peroxidation markers may serve as mechanistically plausible candidate predictors; however, the present evidence base remains heterogeneous in marker selection, assay platform, and standardization, and direct comparative evidence against standard clinic-based models is still limited (20–22).”
From AI-driven cardiovascular risk prediction in patients with diabetes: bridging algorithmic innovation to equitable clinical application (2026) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Oxidative stress plays a central role in the shared pathophysiology of diabetes and cardiovascular disease, with lipid peroxidation representing one of its major downstream consequences.”
From AI-driven cardiovascular risk prediction in patients with diabetes: bridging algorithmic innovation to equitable clinical application (2026) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Studies have shown that oxidized lipid products and related oxidative stress markers may reflect vascular injury, inflammatory activity, and cardiometabolic dysfunction (18–22).”
From AI-driven cardiovascular risk prediction in patients with diabetes: bridging algorithmic innovation to equitable clinical application (2026) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, integrating mechanistic biomarkers—such as those related to lipid peroxidation—holds potential to improve biological relevance and possibly predictive performance (18–22).”
From AI-driven cardiovascular risk prediction in patients with diabetes: bridging algorithmic innovation to equitable clinical application (2026) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“The association between lipid peroxidation and diabetic cardiovascular complications has been extensively discussed in the literature (18, 19, 21, 22).”
From AI-driven cardiovascular risk prediction in patients with diabetes: bridging algorithmic innovation to equitable clinical application (2026) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
Sies, H., & Jones, D. P. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0230-3 · Cited by 5,335
Oxidative Stress: Harms and Benefits for Human Health
Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., Squadrito, F., Altavilla, D., & Bitto, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8416763 · Cited by 4,837
Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy
Forman, H. J., & Zhang, H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00233-1 · Cited by 2,900
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Cuadrado, A., Rojo, A. I., Wells, G., Hayes, J. D., Cousin, S. P., Rumsey, W. L., Attucks, O. C., Franklin, S., Levonen, A., Kensler, T. W., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0008-x · Cited by 1,510
Incalza, M. A., D’Oria, R., Natalicchio, A., Perrini, S., Laviola, L., & Giorgino, F. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.05.005 · Cited by 1,419
Nicholls, S. J., Lincoff, A. M., Garcia, M., Bash, D., Ballantyne, C. M., Barter, P. J., Davidson, M. H., Kastelein, J. J. P., Koenig, W., McGuire, D. K., et al. (2020) · JAMA · doi:10.1001/jama.2020.22258 · Cited by 1,028
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
Geraldes, P., & King, G. L. (2010) · Circulation Research · doi:10.1161/circresaha.110.217117 · Cited by 1,019
Research works printed but not linked: 5
- Engler, 2017, Role of dietary omega-3 fatty acids in hypertension, Ann. Nurs. Pract., 4, 1077
- Nuñez-Musa, 2024, Type 2 diabetes mellitus and cardiovascular disease: unraveling the complex interplay, Acta Sci. Nutr. Health, 8, 45
- Pardina, 2024, Molecular mechanisms involved in hyperglycemia-induced cellular damage, 1814
- Tang, 2018, Oxidative stress and cardiovascular risk in type 1 diabetes mellitus: insights from the DCCT/EDIC study, J. Am. Heart Assoc., 7, e008368, 10.1161/JAHA.117.0083 · DOI
- Wilcox, 2021, Oxidative stress in hypertension and diabetic nephropathy: role of antioxidant mimetics, Antiox Redox Sign, 34, 1236, 10.1089/ars.2020.8115 · DOI
Cited by
Sorted by citations
Antioxidants and Reactive Oxygen Species: Shaping Human Health and Disease Outcomes
Manful, C. F., Fordjour, E., Subramaniam, D., Sey, A. A., Abbey, L., & Thomas, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157520 · Cited by 193
Roy, B. (2025) · Medical Sciences · doi:10.3390/medsci13030087 · Cited by 103
Diaconescu, B. I., Dumitru, A. V., Tătaru, C. P., Toader, C., Șerban, M., Covache-Busuioc, R.-A., & Eva, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210835 · Cited by 25
Chen, Y., Zhu, J., Gui, H., Liu, M., Zhang, Y., Wu, Z., Liu, C., & Wang, M. (2026) · Antioxidants · doi:10.3390/antiox15070803 · Cited by 8
Martinc, B. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113197 · Cited by 5
A Microfluidic Device for Detecting the Deformability of Red Blood Cells
Liu, W., Xie, L., Yang, J., Gong, X., Sun, D., & Zhang, C. (2025) · Biosensors · doi:10.3390/bios15110758 · Cited by 4
Jing, H., Cai, W., Li, X., Zhong, X., Dong, S., Liu, P., Liu, X., Jin, Y., & Wei, C. (2025) · Journal of Molecular Medicine · doi:10.1007/s00109-025-02607-z · Cited by 4
Athanasiadis, V., Giannopoulou, M., Sarlami, G., Bozinou, E., Varagiannis, P., & Lalas, S. I. (2025) · Foods · doi:10.3390/foods14213653 · Cited by 2
Zhao, B., Tian, Y., Yu, M., Han, J., Chen, Z., Zhang, J., Liu, J., Geng, L., & Lei, Y. (2026) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-025-05540-6 · Cited by 2
Jiang, M., Mo, F., Cao, G., Li, S., Fu, W., & Wang, L. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104219 · Cited by 2
Targeting endothelial oxidative stress in hypertension
Liu, J. (2025) · Open Medicine · doi:10.1515/med-2025-1361 · Cited by 1
Wang, N., Yang, S., Li, C., Wang, Z., Ma, Y., Lu, W., Guo, M., Xue, Y., Wu, F., Zhang, M., et al. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121685 · Cited by 1
Oxidative Stress in Dry Eye Disease: Molecular Mechanisms and Emerging Therapeutic Strategies
Tang, T., Yang, J., & Yin, H. (2026) · Biomolecules · doi:10.3390/biom16050718 · Cited by 1
Signorini, C., Moretti, E., Liguori, L., Leoni, E., Marcucci, C., Salvatici, M. C., & Collodel, G. (2026) · Biology · doi:10.3390/biology15100760 · Cited by 1
Zhao, J.-Y., Shu, Y., Wang, S.-H., & Wu, H. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1834237 · Cited by 1
Varrassi, G., Tran, Y. V., Farì, G., Encinas, M. N., Corriero, A., Puntillo, F., Pham, P. V., & Leoni, M. L. G. (2026) · Antioxidants · doi:10.3390/antiox15080948 · Cited by 2
Therapeutic Potential of Solanum macrocarpon in Uterine Leiomyoma: In Vivo and In Silico Approaches
Ogunlakin, A. D., Anejukwo, D. S., Asaleye, O., Olusegun, O. V., Balogun, H., Ayeni, P. O., Ayomipo, M. A., Berena, G. A., Okpala, E. O., Adelakun, A. D., et al. (2026) · The FASEB Journal · doi:10.1096/fj.202601240rrr · Cited by 1
Shadab, A. (2026) · Immunological Investigations · doi:10.1080/08820139.2026.2714418 · Cited by 1
Li, H., Xu, Z., Cen, Y., & Liu, X. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1831220
“The association between lipid peroxidation and diabetic cardiovascular complications has been extensively discussed in the literature (18, 19, 21, 22).”
InfluentialSamaniego, O. P., Gutiérrez, Ó. G. H., Aguilar, P. S. T., Gonza-Tito, P. A., Salazar, P. C. V., & Contreras, J. H. P. (2025) · Nutrición clínica y dietética hospitalaria/Nutrición clínica, dietética hospitalaria · doi:10.12873/454puelles
Vijukumar, A., Singh, G., Aggarwal, M., Sharma, A., & Sandhu, N. K. (2026) · Springer eBooks · doi:10.1007/978-3-032-11752-6_17
Seth, A., Bandyapadhyay, S., Palui, A., & Chatterjee, M. (2026) · Springer eBooks · doi:10.1007/978-3-032-11752-6_21
Bibi, T., Bano, S., Shabbir, A., & Khan, S. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112785
Research progress on ROS-responsive hydrogels for the treatment of osteoporosis: a review
Zhao, Y., Lan, W., Zhang, L., Xu, D., & Wang, C. (2026) · Biomedical Materials · doi:10.1088/1748-605x/ae5566
Thuy, L. T. T., Hai, H., Anh, P. T., Chi, N. B. T., Duc, P. M., & Hermiston, M. L. (2026) · Biochemistry · doi:10.5772/intechopen.1013837
Li, J., Li, C., Yang, C., Zhu, Z., Ran, H., Liu, B., Zhang, Y., & Xiang, Y. (2026) · Peptides · doi:10.1016/j.peptides.2026.171489
Ozoani, H. A., Okolo, K. O., Dooka, B. D., Obasi, C. N., Abdulai, P. M., & Orisakwe, O. E. (2026) · Environmental Toxicology · doi:10.1002/tox.70108
Wang, Y., Hongning, L. I., 张仲远, Kong, X., Li, H., Qian, W., & Ma, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1809146
Tan, F., Hu, R., Du, J., & Ya, S. (2026) · Inflammation · doi:10.1007/s10753-026-02515-5
Diabetes-driven oxidative stress and calcium dysregulation in gametogenesis and early fertilization
Siddiqui, S. F., Siddiqui, H. F., Maggio, V., Rizzo, M., & Nomikos, M. (2026) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2026.109345
Yin, S., Hu, X., Cai, H., Jiang, R., Li, J., & Cheng, Y. (2026) · Respiratory Research · doi:10.1186/s12931-026-03675-6
Anwar, M., Ayub, F., & Nadeem, M. A. (2025) · Axis Journal of Agriculture & Biological Sciences · doi:10.67129/s95wgq35
Wakens, A., Joseph, D. E., & Rambharose, S. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113354
Du, L., Liu, Y., Zhu, K., Lin, Z., Hua, B., Peng, J., & Cao, C.-M. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06075-2
Gao, Z., Li, J., Wang, L., & Jiang, D. (2026) · Mitochondrion · doi:10.1016/j.mito.2026.102176
Darwich, N. A., Hajj, R. E., & Khalil, M. I. M. (2026) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.70056
Pharmacologic strategies in prediabetic neuropathy
Fuentes‐Mendoza, J. M., Concepción‐Zavaleta, M. J., Garcia-Ramirez, Suyón-Ríos, N. A., Urteaga, L. A. C., Basurto-Ayala, A., & Paz‐Ibarra, J. (2026) · Current Medical Research and Opinion · doi:10.1080/03007995.2026.2706312
Variety-specific polyphenol accumulation and antioxidant activity differences in apple fruits
Chen, Y., Cai, R., Chen, S., Hong, K., Zhang, C., Zhang, Z., Zhang, Y., & Zhu, L. (2026) · Journal of Food Measurement & Characterization · doi:10.1007/s11694-026-04814-9
Maternal circadian disruption during pregnancy and offspring diabetic cardiovascular disease risk
Saedi, S., Bing, H., Wu, J., Gao, Y., Wang, C., Chu, Q., & Xia, Z. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1879135
Oxidative Stress Biomarkers in Pediatric and Early-Stage Type 1 Diabetes: Toward Redox Phenotyping
Mittal, R., Alberti, A., Shivakumar, R., Selvan, L., Gupta, V., Aggarwal, A., Patel, V., Blaschke, C. E., Alipour, F., & Hirani, K. (2026) · Antioxidants · doi:10.3390/antiox15081044
Chekroun-Bechlaghem, N., Belyagoubi-Benhammou, N., Kaid, Z., Zitouni, A., Haci, I. A. E., Bouchama, A., & Djafri, A. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.71618
Phytochemical Profiling and Biological Activities of Moroccan Rhus pentaphylla
En-Naciri, F.-E., Martin, P., Vian, M. A., Joly, N., Sahri, N., & Alaoui, A. (2026) · Molecules · doi:10.3390/molecules31203640
Ali, M., Cao, X., Jaitham, U., Jeeno, P., Wongta, A., Kawichai, S., Yadoung, S., & Hongsibsong, S. (2026) · Toxics · doi:10.3390/toxics14090771
Ge, X., Lai, C., Huang, C., Yong, Q., & Du, Y. (2026) · Journal of Food Science · doi:10.1111/1750-3841.71482
Rohman, N., Ardiansah, B., Wukirsari, T., Ilham, M. I., Anita, Y., Putra, A. B. N., Palupi, K. D., Ariyani, T., Lo, L., Menéndez, J. C., et al. (2026) · South African Journal of Chemical Engineering · doi:10.1016/j.sajce.2026.101010
Li¹², M., Li², Y., Gao², Y., Duan², W., Zheng², G., & Zhang¹², F. (2026) · Research Square · doi:10.21203/rs.3.rs-10660436/v1
Liu, J., Liu, Y., Liao, J., Tan, J., Li, C., Yu, Y., Hu, C., Cheng, F., Feng, C., Yu, X., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01810
Gao, Z., Li, J., & Jiang, D. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.122885
Kong, X., Ren, H., He, J., Pei, K., Zhang, H., Liu, H., Song, Z., Liu, Y., Wei, Z., Chen, Y., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19101602
Hu, L., & Yang, M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1989794
Strategies for the prevention and treatment of hypertension and recent advances
陳佳慧, Jiang, J., & Rui, X. (2026) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2026.100650
Metadata
- Authors
- Nuñez-Selles, A. J., Nuñez-Musa, R. A., & Guillen-Marmolejos, R. A.
- Venue
- Frontiers in Molecular Biosciences
- Publisher
- Frontiers Media SA
- Published
- 2025-05-26
- Volume
- 12
- Pages
- 1611842-1611842
- ISSN
- 2296-889X (ISSN-L)
- PMC
- PMC12146192
- OpenAlex
- W4410729041
- Cited by
- 51
- References
- 239
- Citations by year
- 2026: 42 · 2025: 9
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Molecular Biosciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fondo Nacional de Ciencia y Tecnología
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- oxidative stress, hypertension, diabetes mellitus, antioxidant therapy, reactive oxygen species, NADPH oxidase, mitochondrial dysfunction, endothelial dysfunction, vascular remodeling, hyperglycemia, beta-cell failure, insulin resistance, AGE-RAGE signaling pathway, polyol pathway, protein kinase C, F2-isoprostanes, 8-hydroxy-2'-deoxyguanosine, superoxide dismutase, glutathione peroxidase, Nrf2, gut microbiota, mitochondria-targeted antioxidants, NOX inhibitors, Mediterranean diet, physical activity, cardiometabolic dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
